Back
Candel Therapeutics Stock Predictions
Pacaso has reserved the Nasdaq ticker PCSO and is offering shares at just $2.80 - but only until May 29.
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.*Pacaso recently received their ticker reservation with Nasdaq
Sell
44
CADL
Candel Therapeutics
Last Price:
$5.64
Seasonality Move:
-29.39%
7 Day Trial
ALL ACCESS PASS
$
7
Your Portfolio's Boring. This Company Isn't And It's Early
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai. *RAD Intel recently received their ticker reservatioCandel Therapeutics Stock Forecast
-
Over the next 52 weeks, Candel Therapeutics has on average historically risen by 184.5% based on the past 3 years of stock performance.
-
Candel Therapeutics has risen higher in 1 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 33.33%
-
Is Candel Therapeutics Stock Undervalued?The current Candel Therapeutics [CADL] share price is $5.43. The Score for CADL is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
-
CADL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Candel Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, Candel Therapeutics has on average historically risen by 184.5% based on the past 3 years of stock performance.
Candel Therapeutics Stock Rating
Sell
44
Candel Therapeutics (CADL)
is a Sell
Is Candel Therapeutics overpriced?
-
Candel Therapeutics has risen higher in 1 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 33.33%
Candel Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
candeltx.com
52-Week Data
52-Week High:
14.60
52-Week Low:
3.79
Prediction Charts
Market Cap:
272.1M
Price in USD:
5.43
Volume:
691K
Beta:
-0.94
Technical Analysis
SMA50:
5.71
SMA100:
6.98
SMA200:
6.49
52-Wk Change:
-49.2%
Stock Predictions
-
Is Candel Therapeutics stock public?Yes, Candel Therapeutics is a publicly traded company.
-
What is the Candel Therapeutics stock quote today?The Candel Therapeutics stock price is 5.43 USD today.
-
How to buy Candel Therapeutics stock online?You can buy Candel Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| May-6 | 4.95 | 4.59 | 4.98 | 4.50 |
| May-7 | 4.62 | 4.54 | 4.73 | 4.44 |
| May-8 | 4.50 | 4.76 | 4.85 | 4.34 |
| May-9 | 4.75 | 4.81 | 4.92 | 4.63 |
| May-12 | 5.02 | 5.01 | 5.19 | 4.82 |
| May-13 | 5.10 | 5.40 | 5.59 | 5.03 |
| May-14 | 5.46 | 5.34 | 5.54 | 5.25 |
| May-15 | 5.31 | 5.11 | 5.37 | 5.03 |
| May-16 | 5.16 | 5.35 | 5.50 | 5.09 |
| May-19 | 5.34 | 5.70 | 5.71 | 5.21 |
| May-20 | 5.76 | 5.91 | 5.94 | 5.52 |
| May-21 | 5.82 | 5.47 | 5.93 | 5.44 |
| May-22 | 5.34 | 5.42 | 5.65 | 5.31 |
| May-23 | 5.26 | 5.43 | 5.47 | 5.18 |
Candel Therapeutics Earnings
Candel Therapeutics Earnings Report: Per Share Candel Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Candel Therapeutics Forecast Revenue Growth
Candel Therapeutics Stock Analysis: Historical quarterly revenues per share for Candel Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.61 per share, and a decrease next year of $0.09 per share.
* Candel Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.